Replies to post #35357 on Biotech Values

[ghmm]

David,

I saw (heard) you don't take payment from the companies you profile (which is refereshing) but how do you determine which companies you cover?

Are you the one who follows REX? I am more optimistic then some on OvaRex but more pessimestic then a lot of REX shareholders on the outcome (very strong in the middle :)) I started going through some old studies, papers and United's R&D day info and have some thoughts (currently mostly in my head) I was hoping to engage others in some discussion on the merits. I know poorgradstudent had some opinions curious if you do as well.